جستجوی استاد راهنمای دانشگاهی

Samantha Kingمشاهده پروفایل

استاد

• Cultural Studies
• Sociology
• Health Studies
• +۵ مورد دیگر

Samantha King is a Professor in the Department of Kinesiology and Health Studies at Queen's University. She holds a PhD from the University of Illinois at Urbana-Champaign. Her interdisciplinary research integrates feminist, queer, and critical race theories to examine the intersections of health, sport, and the body. She leads the King Research Group, based in KINE 206J & 301V offices. King's research interests span topics such as drug cultures, food politics, and the sociology of sport. Her influential work includes the book Pink Ribbons, Inc: Breast Cancer and the Politics of Philanthropy , adapted into an NFB documentary. She explores themes like pharmaceutical use in professional sports, the ecological dimensions of embodiment, and multispecies approaches to sport studies. Her recent publications analyze racial capitalism in NFL pain management, pandemic-era human-animal relations, and the sociological implications of whey protein consumption. She has co-edited volumes on food ethics and bodily embodiment, reflecting her commitment to interdisciplinary dialogue. Her work bridges cultural studies, sociology, and health studies, addressing contemporary issues in sport, medicine, and everyday life. King’s academic contributions include over 30 peer-reviewed articles and edited collections. She has received international attention for critiquing corporate philanthropy in health activism and challenging normative frameworks in sport studies. Her current projects explore multispecies methodologies and the political economies of meat production.

• Machine Learning
• Bioinformatics
• Computational Biology
• +۵ مورد دیگر

Jian Peng is an Assistant Professor in the Department of Computer Science at the University of Illinois at Urbana-Champaign. His research focuses on computational biology, machine learning, and their applications to protein structure prediction, drug design, and molecular modeling. He has contributed to advancements in antibody engineering, protein-ligand docking, and generative models for biological systems. Key research areas include: Machine Learning for Molecular Modeling Protein Structure Prediction Antibody and Peptide Design Genomics and Single-Cell Analysis Structure-Based Drug Discovery His work emphasizes integrating deep learning techniques with biological datasets to address challenges in precision medicine, drug development, and systems biology. Notable achievements include developing the FastFold system to accelerate AlphaFold training and pioneering flow-based methods for antibody design. Awards include the Overton Prize (2020), recognizing contributions to computational biology. His research has been published in top journals and conferences, spanning topics from protein mutation prediction to geodesic-based immune complex modeling.

• Cancer Genomics
• Precision Medicine
• Colorectal Cancer Research
• +۵ مورد دیگر

Tobias Sjöblom serves as Professor and Head of Department at Uppsala University's Department of Immunology, Genetics and Pathology, where he leads the Cancer Precision Medicine research program. His work bridges clinical oncology and molecular biology, with particular focus on translating genomic findings into clinical applications for cancer patients. His research interests center on cancer genomics, precision medicine, and molecular diagnostics, with extensive work on colorectal cancer biology and treatment. Sjöblom's laboratory investigates how genetic variations influence cancer development, progression, and response to therapy, particularly focusing on pharmacogenomic biomarkers that can guide personalized treatment decisions. His work spans from basic molecular mechanisms to clinical applications, with strong emphasis on translating research findings into clinical practice. Analyzing his recent publication record reveals a clear trajectory toward precision oncology applications, with increasing focus on liquid biopsy technologies, AI-assisted diagnostics, and biomarker-driven treatment strategies. His research demonstrates a consistent pattern of investigating how specific genetic alterations (particularly in NAT2, CYP2D6, and other metabolic enzymes) can be leveraged for targeted cancer therapies. The interdisciplinary nature of his work is evident in collaborations spanning molecular biology, clinical oncology, bioinformatics, and medical imaging. Sjöblom has established significant research infrastructure through initiatives like the U-CAN biobank, creating valuable resources for cancer research across Sweden. His leadership extends to developing novel methodologies for cancer genomics and diagnostics, including advanced techniques for mutation detection and tissue analysis. His laboratory maintains strong clinical connections, working closely with oncologists and surgeons to ensure research questions address real clinical challenges. This translational approach has resulted in numerous publications in high-impact journals including Nature, Science, and Cell Death and Disease, demonstrating the significance and quality of his contributions to cancer research.

• Cancer Genetics
• Prostate Cancer
• Genomic Evolution
• +۵ مورد دیگر

Colin Cooper is a Professor of Cancer Genetics at the Norwich Medical School, University of East Anglia. He is also a member of the Metabolic Health and Cancer Studies research groups. His work focuses on genomic evolution, tumor microbiome dynamics, and biomarker development for prostate cancer and musculoskeletal health. Cooper’s recent research explores the interplay between cancer genetics and microbial communities, emphasizing their role in prognosis and treatment outcomes. He investigates clonal evolution in tumors, mutational signatures, and non-invasive diagnostic tools like urinary extracellular vesicles. His collaborations span genomics, microbiology, and clinical applications. 2025: Causes of evolutionary divergence in prostate cancer (Genomics, Precision Medicine) 2024: Applications of urinary extracellular vesicles... (Biomarker Development, Liquid Biopsy) 2023: Caution regarding pan-cancer microbial structure (Methodological Considerations, Microbiome Analysis) In 2022, Cooper received the European Urology Oncology SoMe Award for his contributions. His work is frequently cited and has been featured in media outlets globally, highlighting his impact on cancer and aging research.

Teresa Puthusseryمشاهده پروفایل

دانشیار

• Retinal Neurobiology
• Neurophysiology
• Retinal Degeneration
• +۳ مورد دیگر

Dr. Teresa Puthussery is an Associate Professor in the School of Optometry & Vision Science at the University of California, Berkeley. Her research focuses on retinal neurobiology and neurophysiology, investigating how visual signals are encoded in healthy retinas and disrupted during degeneration. She uses advanced techniques like patch-clamp electrophysiology, immunohistochemistry, and microscopy to study retinal circuits, neurotransmitter receptors, and ion channels. Dr. Puthussery teaches courses on vision science anatomy, physiology, and problem-based learning, including VISION SCIENCE 206B/C and 260C. Her research explores questions such as how retinal neurons extract motion/spatial details, how photoreceptor mutations cause degeneration, and how inner retinal circuits adapt post-photoreceptor loss. Recent work includes studies on ON-type direction-selective ganglion cells, optogenetic therapy for vision restoration, and calcium dynamics in foveal ganglion cells post-degeneration. She collaborates on projects involving primate and rodent models, contributing to understanding retinal disease mechanisms and therapeutic targets. Dr. Puthussery’s lab (retinalab.berkeley.edu) emphasizes translational research, bridging basic science and clinical applications. Her work has been published in journals like Nature and Cell Reports , with a focus on retinal degeneration, synaptic plasticity, and optogenetic interventions. She actively participates in training future vision scientists through Berkeley’s Optometry program and oversees GSI affairs as a faculty advisor.

• Formal Verification
• Software Testing
• Programming Languages
• +۱۲ مورد دیگر

Alastair F. Donaldson is a Professor and Director of Research in the Department of Computing at Imperial College London, where he leads the FastPL research group. His work bridges formal methods, software testing, and programming languages, with a focus on enhancing the reliability of high-performance and parallel software systems. He has held key roles including Director of Research (since 2023) and previously served as Lecturer (2011–2014), Senior Lecturer (2014–2017), and Reader (2017–2020) before being promoted to Professor in 2020. His research interests include formal verification, compiler testing, GPU programming, concurrency, and fuzzing. He has made significant contributions to the verification of GPU kernels, metamorphic testing of graphics drivers, and the development of tools like GPUVerify and GraphicsFuzz. His work combines theoretical rigor with practical impact, demonstrated by the acquisition of his startup GraphicsFuzz by Google in 2018 and his subsequent roles as Senior Software Engineer and Visiting Researcher at Google. His recent publications reflect a sustained focus on compiler and system reliability, with trends in fuzzing, formal specification, and automated testing of complex systems such as WebGPU, CXL cache coherence, and large language models for code generation. His work increasingly integrates empirical validation with formal techniques to uncover subtle bugs in real-world systems. Scientific awards and recognitions include: 2017 BCS Roger Needham Award EPSRC Early Career Fellowship Fellow of the British Computer Society Best Paper awards at EuroSys 2024, MET 2021, IISWC 2019, IWOCL 2019, and ICST 2016 Best Industry Paper at ICST 2024 ACM SIGSOFT Distinguished Paper at ISSTA 2023 ACM SIGPLAN Most Influential OOPSLA Paper Award (2012 paper), awarded in 2022 Best Student Paper at PPoPP 2014 He has advised numerous PhD students and leads a vibrant research group. He has secured significant research funding and collaborates extensively with industry and academia. His service includes leadership roles such as General Chair of PLDI 2020, PC Chair of ECOOP 2019, and Steering Committee Chair of PLDI (2022–2025). He also serves on the advisory board of PACM-PL and on program committees for top venues including POPL, OOPSLA, PLDI, ICSE, and ISSTA. He leads the FastPL research group, which focuses on the design and implementation of programming tools and techniques for reliable software. The group conducts cutting-edge research in compiler testing, formal methods, and high-performance systems, fostering collaboration across academia and industry.

Alicia Cheمشاهده پروفایل

استادیار

• Neuroscience
• Developmental Neuroscience
• Behavioral Neuroscience
• +۵ مورد دیگر

Alicia Che is an Assistant Professor of Psychiatry at Yale University School of Medicine and serves as Director of Graduate Admissions for the Interdepartmental Neuroscience Program. She joined the Yale Department of Psychiatry in 2021 after completing her postdoctoral fellowship with Dr. Natalia De Marco García at Weill Cornell Medical College and Dr. Gord Fishell at NYU. Her research is conducted through the Che Lab at Yale, where she investigates how early life experiences impact brain circuit assembly and mature function in models of psychiatric illness. Yale School of Medicine, Department of Psychiatry Interdepartmental Neuroscience Program Center for Brain & Mind Health Division of Molecular Psychiatry Wu Tsai Institute Yale Center for the Science of Cannabis and Cannabinoids Dr. Che earned her Ph.D. in Physiology and Neurobiology from the University of Connecticut in 2014, where she worked in the laboratory of Dr. Joseph LoTurco. She received her B.S. with triple majors in Biology, Physics, and Physical Chemistry from Pacific Lutheran University in Washington state in 2009. Her research focuses on understanding developmental trajectories following early life experiences to develop diagnostics and early interventions for psychiatric illnesses. Dr. Che's research examines how sensory inputs, social bonding, stress, and substance exposure impact brain development. She employs a multi-dimensional approach to assess transcriptional, circuit, neuronal activity, and behavioral changes across the entire developmental timeline. Her lab currently focuses on four specific areas: the role of oxytocin in social behavior development, circuit dysfunction in PTSD, early-life cannabinoid exposure effects, and the impact of early life stress on development and adulthood. She utilizes advanced techniques including mouse genetics, slice electrophysiology, and longitudinal in vivo 2-photon imaging on behaving animals. Her most recent publications demonstrate significant contributions to understanding neural circuit development, PTSD mechanisms, and the effects of early life experiences on brain function. Her work spans from molecular neuroscience to behavioral outcomes, with publications in top journals including Nature, Neuron, and Nature Communications. Her research has revealed important insights into how translaminar neuronal activity strengthens cortical columns, how oxytocin facilitates social touch development, and how PTSD affects brain transcriptomics. NARSAD Young Investigator Award (2020) K99/R00 Pathway to Independence Award from NINDS (2019) Dr. Che's work has significant implications for understanding and treating neurodevelopmental disorders, PTSD, and the consequences of early life experiences on mental health. She collaborates extensively with researchers across Yale and beyond, with frequent co-authorship with colleagues including Lin Lin, Alex Kwan, and Christopher Pittenger. Her research program bridges basic neuroscience with clinical applications, aiming to translate findings into potential interventions for psychiatric conditions.

Lindsey Kentمشاهده پروفایل

استاد

• Psychiatric Genetics
• Neuroscience
• Developmental Disorders
• +۴ مورد دیگر

Lindsey Kent is a Professor at the University of St Andrews' School of Medicine, where she serves as Deputy Head and Director of Admissions. Her research focuses on the biological foundations of psychiatric disorders, particularly ADHD and developmental language disorders. Education: Medicine (Aberdeen University, 1989), PhD (University of Birmingham, 1998) Academic Appointments: Wellcome Trust Fellow (1999), University Lecturer (University of Cambridge, 2003), Reader (University of St Andrews, 2007) Research Trends: Dr. Kent's work explores psychiatric genetics, neurodevelopmental disorders, and molecular mechanisms through genome-wide association studies, exome sequencing, and genetic epidemiology. Key Collaborations: Psychiatric Genomics Consortium, EAGLE Consortium, 23andMe Technical Focus: ATP2C2 gene variants, TNR gene associations, polygenic risk architectures Awards: Fellow of the Higher Education Academy (2000) Academic Contributions: She has directed two Wellcome Trust-funded projects on ADHD genetics and co-authored over 91 peer-reviewed publications, including significant studies in Nature Communications and Human Molecular Genetics . Her editorial roles include serving on the American Journal of Medical Genetics board (2007–2014).

Soeren Lienkampمشاهده پروفایل

استادیار

• Molecular Biology
• Genetics
• Developmental Biology
• +۵ مورد دیگر

Prof. Dr. Soeren Lienkamp is an Assistant Professor at the Institute of Anatomy , Faculty of Medicine , University of Zurich . His work bridges digital education and genetic research , focusing on enhancing medical teaching through innovative formats. Research Interests : Genetics, developmental biology, kidney disease modeling, CRISPR applications, digital medical education, and advanced microscopy. Methodologies : Combines Xenopus tropicalis models, deep learning , and bioengineering to study genetic kidney disorders and improve diagnostic tools. Publication Trends : His recent articles highlight predictable genome editing , 3D imaging technologies , and mechanistic insights into kidney and eye development. Earlier works focus on ciliary function , Wnt signaling , and metabolic stress in renal cells.

Jeff S Abramsonمشاهده پروفایل

استاد

• Membrane Transport Proteins
• Structural Biology
• Sugar Transporters
• +۵ مورد دیگر

Jeff S Abramson is a Professor of Physiology in the David Geffen School of Medicine at the University of California Los Angeles (UCLA). His research focuses on the structural and functional characterization of membrane transport proteins, particularly sugar transporters and mitochondrial channels. He maintains an active laboratory investigating the molecular mechanisms of cellular transport processes. Dr. Abramson's primary research interests center on membrane transport proteins, with particular emphasis on sugar symporters and voltage-dependent anion channels (VDACs). His work combines structural biology, biophysics, and biochemistry to understand the molecular mechanisms of transport, including conformational changes during transport cycles, substrate recognition, and regulation by membrane potential. His research has significant implications for understanding metabolic disorders, mitochondrial function, and potential therapeutic targets. Analysis of Dr. Abramson's publication record reveals a consistent focus on membrane protein structure-function relationships over the past two decades. His work demonstrates expertise in X-ray crystallography, cryo-electron microscopy, and functional assays to characterize transport proteins. Recent publications show increasing emphasis on mitochondrial biology, particularly VDAC structure and function, while maintaining his longstanding interest in sugar transport mechanisms. His research bridges fundamental biophysical principles with potential biomedical applications in metabolic diseases. Dr. Abramson has been awarded multiple NIH grants supporting his research, including the R35GM135175 grant titled 'Deciphering molecular details of cellular sugar transport and their roles in disease' (2020-2024), R01GM124783 'Functional and structural studies of unique pathogenic transporters involved in glycobiology' (2017-2021), and R01GM078844 'Structural and functional characterization of sugar transporters in health and disease' (2006-2020). As Principal Investigator, Dr. Abramson has mentored numerous graduate students and postdoctoral researchers. His laboratory has made significant contributions to understanding the structure-function relationships of membrane transport proteins through collaborations with researchers across multiple disciplines. The lab utilizes advanced techniques including X-ray crystallography, cryo-EM, electrophysiology, and computational modeling to address fundamental questions about membrane protein mechanisms. Dr. Abramson's laboratory is part of UCLA's broader research ecosystem focused on structural biology and membrane protein research. His work intersects with several research centers at UCLA including those focused on metabolic diseases and structural biology. The lab maintains active collaborations with researchers specializing in biophysics, computational modeling, and disease mechanisms to translate basic findings into potential biomedical applications.

Scott C. Garmanمشاهده پروفایل

استاد

• Structural Biology
• Glycoproteins
• Lysosomal Storage Diseases
• +۲ مورد دیگر

Scott Garman is Professor of Biochemistry at UMass Amherst, focusing on structural biology of glycoproteins in human diseases. PhD from Harvard University. Research areas: Lysosomal enzyme mechanisms in storage diseases (Fabry, Schindler); Malaria surface protein structures; Antibody-receptor interactions. Utilizes X-ray crystallography to study enzyme mutations causing disease. Key findings: Determined structures of α-galactosidase (Fabry disease) and α-NAGAL (Schindler disease), revealing molecular bases for enzyme dysfunction. Developed models for enzyme trafficking and substrate processing. Laboratory: Investigates protein folding diseases and develops therapeutic strategies. Collaborates on malaria vaccine development and antibody engineering.

Retsef Leviمشاهده پروفایل

استاد

• Food Supply Chain Analytics
• Supply Chain Optimization
• Health Systems
• +۷ مورد دیگر

Retsef Levi is the J. Spencer Standish (1945) Professor of Operations Management at the MIT Sloan School of Management, affiliated with the MIT Operations Research Center. He co-directs the Leaders for Global Operations (LGO) Program. His work focuses on data-driven decision models for healthcare systems, supply chain optimization, and risk management. Levi holds a PhD in Operations Research from Cornell University and has led industry collaborations with major hospitals and organizations like the FDA and Walmart Foundation. Education: PhD in Operations Research, Cornell University, 2005 Bachelor’s in Mathematics, Tel-Aviv University, 2001 Research Interests: Levi’s research addresses complex decision-making under uncertainty in healthcare, supply chains, and logistics. Key areas include food safety analytics, risk-based sampling, and predictive modeling for zoonotic diseases. He designs algorithms for inventory control, appointment scheduling, and healthcare resource allocation. Articles Overview: Recent work spans AI-driven epidemiological models, supply chain cybersecurity, and agricultural market interventions. His articles emphasize practical applications of operations research in healthcare and public health. Awards: NSF Career Grant INFORMS Optimization Prize (2008) Wagner Prize (2013) Harold W. Kuhn Award (2016) Advising & Grants: Advised 10 PhD students and 34 master’s students. Led multi-million-dollar projects like the Walmart Foundation initiative for China’s food safety. Active in hospital process optimization and FDA risk management contracts. Labs & Teams: Runs MIT’s Food Supply Chain Analytics and Sensing Initiative, collaborating with global partners on predictive risk tools and healthcare analytics.

Muhammad Ali Gulzarمشاهده پروفایل

استادیار

• Fault Localization
• Big Data systems
• Data Intensive scalable computing
• +۵ مورد دیگر

Muhammad Ali Gulzar is an Assistant Professor in the Computer Science Department at Virginia Tech and an Amazon Scholar at Amazon Web Services. His research focuses on improving developer productivity through automated debugging and testing for applications in emerging domains, including data-intensive software such as dataflow programs, ML/AI applications, and computational notebooks. Education Ph.D. in Computer Science from University of California, Los Angeles (Google Ph.D. Fellow 2017-2020) Research Interests Gulzar's research spans three primary areas: (1) automated tracking-code localization techniques in web applications, (2) re-engineering testing and debugging for data-intensive applications, and (3) advancing current testing and debugging practices in Federated Learning Applications. His work addresses the challenges of debugging in complex systems where traditional approaches fail due to the scale and distributed nature of modern applications. His research has significant implications for improving software quality, developer productivity, and accessibility in web applications. Research Trends Recent publications demonstrate a strong focus on debugging and testing challenges in emerging application domains. His work bridges traditional software engineering with machine learning, data-intensive systems, and web technologies. Notably, he has made significant contributions to Federated Learning debugging (FedDebug), accessibility challenges in ad-driven web applications, and semantic caching for Large Language Models. His approach often combines novel algorithmic insights with practical implementations that address real-world challenges in software development and maintenance. Scientific Awards Google Ph.D. Fellow (2017-2020) $1.1 million NSF award for Federated Learning research ACM CCS 2024 Distinguished Artifact Award Advising and Grants Gulzar leads a productive research group with multiple students contributing to publications in top-tier venues. His NSF-funded research on Federated Learning demonstrates his ability to secure competitive funding for innovative projects. His advising style appears to emphasize practical impact alongside theoretical contributions, with students often taking lead roles in publications. Current research directions include debugging techniques for Large Language Models, accessibility challenges in modern web applications, and novel testing approaches for distributed data processing systems.

Jason Yiمشاهده پروفایل

استادیار

• Neuroscience
• Molecular Neuroscience
• Developmental Neuroscience
• +۶ مورد دیگر

Dr. Jason Yi is an Assistant Professor of Neuroscience at Washington University School of Medicine (WashU Medicine). His research focuses on understanding the molecular pathways that shape nervous system development and function, with particular emphasis on autism spectrum disorders (ASD). He leads the Yi Lab, which investigates the role of the ubiquitin ligase UBE3A in the brain and its implications for neurodevelopmental disorders. Dr. Yi received his BS in Biochemistry and Molecular Biology from Dickinson College in 2001 and his PhD in Pharmacology from Duke University in 2009. His laboratory is broadly interested in the molecular pathways that shape nervous system development and function, with the ultimate goal of understanding how dysfunction in these pathways contributes to disease. The current focus is on autism spectrum disorders (ASD), using genetic information from human patients to guide in vitro and in vivo experiments employing biochemical, genetic manipulation, cell biological, and microscopy techniques. Dr. Yi's research has significant clinical implications, particularly in understanding how UBE3A dysfunction relates to both Angelman syndrome (caused by lack of UBE3A activity) and autism (caused by excessive UBE3A activity). His lab discovered that a single phosphorylation event in UBE3A turns off its ubiquitin ligase activity, and that mutations in this site are linked to autism. This work bridges disease genetics with a mechanistic understanding of ASD neurobiology and aims to define developmental timepoints for ASD onset. Dr. Yi's research has been recognized with numerous prestigious awards: Ruth K. Broad Biomedical Research Foundation Predoctoral Fellowship (2006) F32 Kirschstein National Research Service Award (2011) Christina Castellana Postdoctoral Fellowship (2011-2014) The University of North Carolina Postdoctoral Award for Research Excellence (2015) Bridge to Independence Award, The Simons Foundation (2017) NARSAD Young Investigator Award, Brain and Behavior Research Foundation (2018) Whitehall Foundation Research Grant (2018) Alfred P. Sloan Foundation Research Fellowship (2019) Dr. Yi's research program is supported by significant grant funding from organizations including The Simons Foundation, Brain and Behavior Research Foundation, and the Whitehall Foundation. His work bridges basic molecular neuroscience with clinical implications for neurodevelopmental disorders, particularly autism spectrum disorders. Through his research, Dr. Yi is contributing to a deeper understanding of the molecular mechanisms underlying ASD, which may ultimately lead to new therapeutic approaches and interventions. The Yi Lab maintains a collaborative research environment focused on cutting-edge neuroscience techniques. The lab combines molecular, cellular, and genetic approaches to study UBE3A function and its role in neurodevelopment. Their work utilizes patient-derived genetic information to guide experimental approaches, ensuring clinical relevance to autism spectrum disorders. Dr. Yi is also actively involved in mentoring graduate students and postdoctoral fellows, contributing to the training of the next generation of neuroscientists.

Zhiming Caiمشاهده پروفایل

استاد مهمان

• Synthetic Biology
• Genitourinary Oncology
• Genomics
• +۴ مورد دیگر

Zhiming Cai is a Visiting Professor at the National Cancer Institute (NCI) and holds multiple leadership roles in China, including President of Shenzhen Medical Association, Deputy Director of Carlson International Oncology Center at Shenzhen University, and Director of the Guangdong Key Laboratory of Systemic Biology and Synthetic Biology in Genitourinary Oncology. As an Outstanding Principal Investigator at the Chinese Academy of Science's Institute of Synthetic Biology, he leads groundbreaking research in cancer genomics and synthetic biology. Doctor Philosophiae Honoris Causa, The National Academy of Science of Ukraine Fellow, American Institute for Medical and Biological Engineering (AIMBE) His research focuses on synthetic biology applications for cancer therapy , including engineered cell treatments and artificial gene circuits for tumor targeting. Notable work includes the "Remodeling Tumor Suppressor Theory" and CRISPR-based signal transduction systems that earned recognition from Nobel laureates and top-tier journals. With over 330 publications and an H-Index of 36, Cai's work has appeared in Nature , Cell , and European Urology . His research team has successfully treated over 200 advanced tumor patients using synthetic biology approaches, demonstrating clinical translation of cutting-edge technology. Guangdong Medical Natural Science Award (First Class) May 1st Labor Medal (China's highest worker award) State Council Special Allowance Expert National Model Worker International Genetically Engineering Machine Competition Gold Award Cai directs multiple high-profile research institutions including the National Tumor Genome Application Engineering Laboratory and the Academic Committee of the National and Local Joint Medical Synthetic Biology Engineering Laboratory. His work bridges basic research with clinical applications in genitourinary oncology through systematic biology approaches.